Carroll, G. L., Matthews, N. S., Hartsfield, S. M., Slater, M. R., Champney, T. H., & Erickson, S. W. (1997). The effect of detomidine and its antagonism with tolazoline on stress-related hormones, metabolites, physiologic responses, and behavior in awake ponies. Vet Surg, 26(1), 69–77.
Abstract: Six ponies were used to investigate the effect of tolazoline antagonism of detomidine on physiological responses, behavior, epinephrine, norepinephrine, cortisol, glucose, and free fatty acids in awake ponies. Each pony had a catheter inserted into a jugular vein 1 hour before beginning the study. Awake ponies were administered detomidine (0.04 mg/kg intravenously [i.v.]) followed 20 minutes later by either tolazoline (4.0 mg/kg i.v.) or saline. Blood samples were drawn from the catheter 5 minutes before detomidine administration (baseline), 5 minutes after detomidine administration, 20 minutes before detomidine administration which was immediately before the administration of tolazoline or saline (time [T] = 0), and at 5, 30, and 60 minutes after injections of tolazoline or saline (T = 5, 30, and 60 minutes, respectively). Compared with heart rate at T = 0, tolazoline antagonism increased heart rate 45% at 5 minutes. There was no difference in heart rate between treatments at 30 minutes. Blood pressure remained stable after tolazoline, while it decreased over time after saline. Compared with concentrations at T = 0, tolazoline antagonism of detomidine in awake ponies resulted in a 55% increase in cortisol at 30 minutes and a 52% increase in glucose at 5 minutes. The change in free fatty acids was different for tolazoline and saline over time. Free fatty acids decreased after detomidine administration. Free fatty acids did not change after saline administration. After tolazoline administration, free fatty acids increased transiently. Tolazoline tended to decrease sedation and analgesia at 15 and 60 minutes postantagonism. Antagonism of detomidine-induced physiological and behavioral effects with tolazoline in awake ponies that were not experiencing pain appears to precipitate a stress response as measured by cortisol, glucose, and free fatty acids. If antagonism of an alpha-agonist is contemplated, the potential effect on hormones and metabolites should be considered.
|
Spadavecchia, C., Arendt-Nielsen, L., Spadavecchia, L., Mosing, M., Auer, U., & van den Hoven, R. (2007). Effects of butorphanol on the withdrawal reflex using threshold, suprathreshold and repeated subthreshold electrical stimuli in conscious horses. Vet Anaesth Analg, 34(1), 48–58.
Abstract: OBJECTIVE: To assess the effects of a single intravenous dose of butorphanol (0.1 mg kg(-1)) on the nociceptive withdrawal reflex (NWR) using threshold, suprathreshold and repeated subthreshold electrical stimuli in conscious horses. STUDY DESIGN: 'Unblinded', prospective experimental study. ANIMALS: Ten adult horses, five geldings and five mares, mean body mass 517 kg (range 487-569 kg). METHODS: The NWR was elicited using single transcutaneous electrical stimulation of the palmar digital nerve. Repeated stimulations were applied to evoke temporal summation. Surface electromyography was performed to record and quantify the responses of the common digital extensor muscle to stimulation and behavioural reactions were scored. Before butorphanol administration and at fixed time points up to 2 hours after injection, baseline threshold intensities for NWR and temporal summation were defined and single suprathreshold stimulations applied. Friedman repeated-measures analysis of variance on ranks and Wilcoxon signed-rank test were used with the Student-Newman-Keul's method applied post-hoc. The level of significance (alpha) was set at 0.05. RESULTS: Butorphanol did not modify either the thresholds for NWR and temporal summation or the reaction scores, but the difference between suprathreshold and threshold reflex amplitudes was reduced when single stimulation was applied. Upon repeated stimulation after butorphanol administration, a significant decrease in the relative amplitude was calculated for both the 30-80 and the 80-200 millisecond intervals after each stimulus, and for the whole post-stimulation interval in the right thoracic limb. In the left thoracic limb a decrease in the relative amplitude was found only in the 30-80 millisecond epoch. CONCLUSION: Butorphanol at 0.1 mg kg(-1) has no direct action on spinal Adelta nociceptive activity but may have some supraspinal effects that reduce the gain of the nociceptive system. CLINICAL RELEVANCE: Butorphanol has minimal effect on sharp immediate Adelta-mediated pain but may alter spinal processing and decrease the delayed sensations of pain.
|
|
Kirkwood, J. K. (2000). Animal minds and animal welfare. Vet. Rec., 146(11), 327.
|
Marinsek, N. L., Gazzaniga, M. S., & Miller, M. B. (2016). Chapter 17 – Split-Brain, Split-Mind. In S. Laureys, O. Gosseries, & G. Tononi (Eds.), The Neurology of Conciousness (Second Edition) (pp. 271–279). San Diego: Academic Press.
Abstract: The corpus callosum anatomically and functionally connects the two cerebral hemispheres. Despite its important role in interhemispheric communication however, severing the corpus callosum produces few--if any--noticeable cognitive or behavioral abnormalities. Incredibly, split-brain patients do not report any drastic changes in their conscious experience even though nearly all interhemispheric communication ceases after surgery. Extensive research has shown that both hemispheres remain conscious following disconnection and the conscious experience of each hemisphere is private and independent of the other. Additionally, the conscious experiences of the hemispheres appear to be qualitatively different, such that the consciousness of the left hemisphere is more enriched than the right. In this chapter, we offer explanations as to why split-brain patients feel unified despite possessing dual conscious experiences and discuss how the divided consciousness of split-brain patients can inform current theories of consciousness.
|
Williams, D. O., Boatwright, R. B., Rugh, K. S., Garner, H. E., & Griggs, D. M. J. (1991). Myocardial blood flow, metabolism, and function with repeated brief coronary occlusions in conscious ponies. Am J Physiol, 260(1 Pt 2), H100–9.
Abstract: Studies were performed in the conscious pony instrumented with a Doppler flow probe and hydraulic occluder on the left anterior descending coronary artery (LAD), sonomicrometry crystals and intraventricular micromanometer in the left ventricle, and catheters in the left atrium and anterior interventricular vein. Two-minute LAD occlusions were performed every 30 min continuously or during working hours. Data on release of catabolites (potassium, hydrogen ions, and lactate) and norepinephrine from the initially dysfunctional region were obtained periodically during a regimen of 445 +/- 56 occlusions in six animals. Regional myocardial blood flow was measured (microsphere method) before and after an occlusion regimen in four animals. Marked release of catabolites and norepinephrine from the initially dysfunctional region was noted in association with early occlusions when myocardial segment function was severely reduced. With further occlusions, release of these substances decreased while segment function improved. Blood flow was markedly decreased in the initially dysfunctional region during an early occlusion but was at the control level during a later occlusion. Although the metabolic findings are consistent with protection due to “ischemic preconditioning” and no increase in collateral perfusion, the inverse relationship noted between catabolite release and segment function is best explained by flow-dependent mechanisms. These results, together with the myocardial blood flow data, serve to validate a previous assumption that protection against regional myocardial dysfunction under these conditions is due to increased collateral perfusion.
|
|
Pennisi, E. (1999). Are out primate cousins 'conscious'? (Vol. 284).
|
Gallup, G. G. J. (1985). Do minds exist in species other than our own? Neurosci Biobehav Rev, 9(4), 631–641.
Abstract: An answer to the question of animal awareness depends on evidence, not intuition, anecdote, or debate. This paper examines some of the problems inherent in an analysis of animal awareness, and whether animals might be aware of being aware is offered as a more meaningful distinction. A framework is presented which can be used to make a determination about the extent to which other species have experiences similar to ours based on their ability to make inferences and attributions about mental states in others. The evidence from both humans and animals is consistent with the idea that the capacity to use experience to infer the experience of others is a byproduct of self-awareness.
|
Kozarovitskii, L. B. (1988). [Further comment on the distinction between humans and animals]. Nauchnye Doki Vyss Shkoly Biol Nauki, (3), 42–45.
Abstract: The problem of mind is considered in the aspect of natural scientific and philosophical problem of distinction between human and animal. The widespread confusion of the terms “rudiments”, “elements” of specifically human properties in animals and “biological prerequisites” of these properties are critically analysed. The idea is formulated according to which only in the process of anthropogenesis the rudiments of new social property--mind, conscience--could appear in the developing human beings.
|
|
Crook, J. H. (1983). On attributing consciousness to animals. Nature, 303(5912), 11–14.
|
Grubb, T. L., Foreman, J. H., Benson, G. J., Thurmon, J. C., Tranquilli, W. J., Constable, P. D., et al. (1996). Hemodynamic effects of calcium gluconate administered to conscious horses. J Vet Intern Med, 10(6), 401–404.
Abstract: Calcium gluconate was administered to conscious horses at 3 different rates (0.1, 0.2, and 0.4 mg/kg/min for 15 minutes each). Serum calcium concentrations and parameters of cardiovascular function were evaluated. All 3 calcium administration rates caused marked increases in both ionized and total calcium concentrations, cardiac index, stroke index, and cardiac contractility (dP/dtmax). Mean arterial pressure and right atrial pressure were unchanged; heart rate decreased markedly during calcium administration. Ionized calcium concentration remained between 54% and 57% of total calcium concentration throughout the study. We conclude that calcium gluconate can safely be administered to conscious horses at 0.1 to 0.4 mg/kg/min and that administration will result in improved cardiac function.
|
